DLK Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$270K Sell
2,183
-1,319
-38% -$154K 0.11% 69
2026
Q1
$421K Sell
3,502
-1,234
-26% -$142K 0.17% 54
2025
Q4
$499K Hold
4,736
0.19% 49
2025
Q3
$397K Buy
+4,736
New +$390K 0.15% 56
2025
Q2
Sell
-2,251
Closed -$202K 98
2025
Q1
$202K Hold
2,251
0.08% 69
2024
Q4
$224K Buy
2,251
+68
+3% +$7.01K 0.09% 68
2024
Q3
$248K Hold
2,183
0.1% 79
2024
Q2
$270K Buy
2,183
+25
+1% +$3.22K 0.11% 71
2024
Q1
$285K Hold
2,158
0.12% 66
2023
Q4
$235K Buy
+2,158
New +$224K 0.11% 70

Other funds holding MRK

DLK Investment Management's MRK Position: Q2 2026 in Review

DLK Investment Management reduced its Merck (MRK) stake by 38% in Q2 2026, selling an estimated $154K and leaving 2,183 shares worth $270K. The position accounts for 0.11% of the portfolio, ranked #69.

DLK Investment Management first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $499K in Q4 2025. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • DLK Investment Management held 2,183 shares of Merck worth $270K as of Q2 2026.
  • DLK Investment Management sold 1,319 Merck shares in Q2 2026, an estimated $154K.
  • Merck made up 0.11% of DLK Investment Management's portfolio in Q2 2026, its #69 holding.
  • DLK Investment Management first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • DLK Investment Management's Merck position peaked at $499K in Q4 2025.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on DLK Investment Management's 13F filing for Q2 2026, filed 14 Jul 2026.